Clinical trial Recruiting at 1 site Observational Ages 45 and up

Early diagnosis and intervention for cognitive dysfunction in diabetes patients

Official title: China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study (China-DECODE Study)

Run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · NCT06650969 · Data updated 2026-11-12

This study is trying to find early signs of thinking problems in people over 45 with Type 2 diabetes to help them get better care.

Quick facts

Study typeObservational
Ages45 Years and up
SexAll
Enrollment10000 (estimated)
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedOctober 1, 2016
Main results expectedOctober 1, 2034
Study endsOctober 1, 2034
Registry record updatedOctober 21, 2024
Trial IDNCT06650969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 45 and older who have been diagnosed with Type 2 diabetes.

Probably not a fit

Patients with a history of dementia or significant neurological or psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on individuals aged 45 and older with Type 2 diabetes to assess cognitive function and identify early signs of cognitive decline. Participants will undergo a series of neuropsychological tests, laboratory examinations, brain MRI, and olfactory function measurements to gather comprehensive data on their cognitive health. The study aims to address the current limitations in diagnosing and managing cognitive dysfunction in diabetes patients by collecting and analyzing various biological samples. By enhancing understanding and early intervention strategies, the study seeks to improve outcomes for this vulnerable population.

Why it matters

Potential benefit: If successful, this study could lead to improved early diagnosis and intervention strategies for cognitive dysfunction in patients with Type 2 diabetes.

How similar studies have gone: While there is limited research specifically targeting cognitive dysfunction in diabetes, similar studies have shown promise in understanding the relationship between diabetes and cognitive decline.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥45 years;
* Type 2 diabetes diagnosed according to the American Diabetes Association criteria;
* Willingness and ability to complete systematic neuropsychological tests;
* Understanding of the research procedures and methods, potential benefits and risks of the trial, and sign written informed consent.

Exclusion Criteria:

* Fewer than 6 years of education;
* Left-handedness;
* Dementia;
* Acute metabolic complications such as diabetic ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemic coma within the previous 3 months;
* History or presence of neurological or psychiatric disorders;
* Presence of hypothyroidism;
* History of malignancy, or severe kidney or liver dysfunction.

Where it's running

  • Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.